Abstract:Post-translational modifications of DNA and histones are epigenetic mechanisms, which affect the chromatin structure, ultimately leading to gene expression changes. A number of different epigenetic enzymes are actively involved in the addition or the removal of various covalent modifications, which include acetylation, methylation, phosphorylation, ubiquitination, and sumoylation. Deregulation of these processes is a hallmark of cancer. For instance, G9a, a histone methyltransferase responsible for histone H3 lysine 9 (H3K9) mono- and dimethylation, has been observed to be upregulated in different types of cancer and its overexpression has been associated with poor prognosis. Key roles played by these enzymes in various diseases have led to the hypothesis that these molecules represent valuable targets for future therapies. Several small molecule inhibitors have been developed to specifically block the epigenetic activity of these enzymes, representing promising therapeutic tools in the treatment of human malignancies, such as cancer. In this review, the role of one of these epigenetic enzymes, G9a, is discussed, focusing on its functional role in regulating gene expression as well as its implications in cancer initiation and progression. We also discuss important findings from recent studies using epigenetic inhibitors in cell systems in vitro as well as experimental tumor growth and metastasis assays in vivo.

Structure, Activity, and Function of the Protein Lysine Methyltransferase G9a

G9a - an Appealing Antineoplastic Target

Functional Role of G9a Histone Methyltransferase in Cancer

G9a in Cancer: Mechanisms, Therapeutic Advancements, and Clinical Implications

Structural Biology of Human H3K9 Methyltransferases

Research Progress in Inhibitors of Histone Methyltransferase G9a

Structure-Based Design and Characterization of the Highly Potent and Selective Covalent Inhibitors Targeting the Lysine Methyltransferases G9a/GLP

Delineating the active site architecture of G9a lysine methyltransferase through substrate and inhibitor binding mode analysis: a molecular dynamics study

Protein Lysine Methyltransferase G9a Inhibitors: Design, Synthesis, and Structure Activity Relationships of 2,4-Diamino-7-aminoalkoxy-quinazolines.

The Methyltransferase G9a Regulates HoxA9-dependent Transcription in AML.

A Role for Widely Interspaced Zinc Finger (WIZ) in Retention of the G9a Methyltransferase on Chromatin

GLP and G9a histone methyltransferases as potential therapeutic targets for lymphoid neoplasms

Recognition of H3K9 Methylation by GLP is Required for Efficient Establishment of H3K9 Methylation, Rapid Target Gene Repression, and Mouse Viability.

G9a and Glp Methylate Lysine 373 in the Tumor Suppressor P53

Structure and catalytic mechanism of the human histone methyltransferase SET7/9

Discovery of A 2,4-Diamino-7-aminoalkoxyquinazoline As A Potent and Selective Inhibitor of Histone Lysine Methyltransferase G9a

Writing, erasing and reading histone lysine methylations

Regulation of chromatin structure by site-specific histone H3 methyltransferases

MPP8 mediates the interactions between DNA methyltransferase Dnmt3a and H3K9 methyltransferase GLP/G9a

Lysine-specific methyltransferase Set7/9 in stemness, differentiation, and development

Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins